Swartz Robin — SEC insider filings
SEC reporting owner CIK 1909636. 21 insider filings on record with FilingPulse; latest filed 2026-11-03.
Transaction summary — filings shown
Covers all 21 filings on record, filed 2022-02-09 to 2026-11-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 18 legs across 16 filings — 71,620 shares, $451,365 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: sale of 15,373 shares @ $8.20 ($126,059) in Voyager Therapeutics, Inc., filed 2023-03-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | President | 21 | — | 18 legs · 71,620 sh · $451,365 | 11 |
Insider filings — Swartz Robin
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-03 | 4 | Voyager Therapeutics, Inc. (VYGR) | Grant/award (A): 68,250 @ $0 · Grant/award (A): 318,500 (derivative) @ $0 | EDGAR |
| 2026-02-26 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 6,458 @ $3.77 | EDGAR |
| 2026-02-20 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 3,882 @ $3.44 | EDGAR |
| 2026-02-11 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 4,569 @ $3.85 | EDGAR |
| 2026-02-10 | 4 | Voyager Therapeutics, Inc. (VYGR) | Grant/award (A): 45,000 @ $0 · Grant/award (A): 210,000 (derivative) @ $0 | EDGAR |
| 2025-02-24 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 3,894 @ $4.25 · Grant/award (A): 71,250 @ $0 · Grant/award (A): 142,500 (derivative) @ $0 | EDGAR |
| 2025-02-12 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 6,950 @ $4.45 | EDGAR |
| 2025-01-15 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 3,087 @ $5.09 | EDGAR |
| 2024-12-26 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 6,500 @ $5.65 | EDGAR |
| 2024-04-03 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 1,357 @ $9.88 | EDGAR |
| 2024-02-22 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 3,966 @ $7.45 | EDGAR |
| 2024-02-16 | 4 | Voyager Therapeutics, Inc. (VYGR) | Grant/award (A): 50,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2024-01-19 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 2,543 @ $7.15 | EDGAR |
| 2023-04-05 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 1,259 @ $7.83 | EDGAR |
| 2023-03-22 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 3,654 @ $7.76 | EDGAR |
| 2023-03-17 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 15,373 @ $8.20 | EDGAR |
| 2023-02-22 | 4 | Voyager Therapeutics, Inc. (VYGR) | Grant/award (A): 40,000 @ $0 · Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2023-01-19 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 1,396 @ $9.57 · Sale (S): 792 @ $10.34 | EDGAR |
| 2022-04-06 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 1,527 @ $8.25 | EDGAR |
| 2022-03-23 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 4,362 @ $8.29 · Sale (S): 51 @ $8.68 | EDGAR |
| 2022-02-09 | 4 | Voyager Therapeutics, Inc. (VYGR) | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-05-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1909636 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs